chartexchange

MLTX
MoonLake Immunotherapeutics Class A
stockNASDAQ

At CloseOct 2, 2026 3:59:59 PM EDT
11.41USD-0.523%(-0.06)1,827,970
Pre-marketOct 2, 2026 8:46:30 AM EDT
11.72USD+2.214%(+0.25)
After-hoursOct 2, 2026 4:01:30 PM EDT
11.88USD+4.119%(+0.47)
Loading…
Loading…
971.92M
Healthcare
Biotechnology
HQ
Zug, Switzerland
Previous Close
$11.47
Beta
1.21
52-Week High
$23.29 2026-06-22
52-Week Low
$8.18 2025-10-07
SMA 50
$15.15
SMA 200
$16.77
Avg. Vol 10D
1.80M
Avg. Vol 30D
1.56M
Avg. Vol 90D
1.35M
Relative Vol
1.17
72.92M
0.3100%
1,400,000
2,125
Nov 4, 2026 (30d)
Sep 30, 2026
MLTX Profile

moonlake immunotherapeutics ag is a clinical-stage biopharmaceutical company leveraging revolutionary nanobody® technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.

MLTX Performance
PeriodPriceDateChangeBeta
1W11.562026-09-28-1.21%-1.444
1M15.012026-09-04-23.92%0.977
3M18.882026-07-06-39.51%0.826
6M16.982026-04-06-32.74%1.367
1Y8.662025-10-06+31.87%1.210
2Y55.282024-10-04-79.34%—
5Y12.882022-04-07-11.34%0.668
MLTX Stock Summary

MoonLake Immunotherapeutics Class A (NASDAQ:MLTX) stock price today is $11.42, and today's volume is 1,827,970. MLTX is down 0.436% today. The 30 day average volume is 1.56M. MLTX market cap is $971.92M with 85.11M shares outstanding.